Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.21.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Convertible  preferred shares
Common shares
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period (shares) at Dec. 31, 2018     3,000 54,151,000        
Balance at beginning of period at Dec. 31, 2018 $ 39,935 $ (1,641)   $ 54 $ 189,929 $ (2,982) $ (147,066) $ (1,641)
Increase (Decrease) in Stockholders' Equity                
Net loss (25,469)           (25,469)  
Foreign currency translation adjustment 973         973    
Unrealized gain (loss) on investments 14         14    
Stock based compensation expense 5,374       5,374      
Issuance of common stock resulting from exercise of stock options (shares)       279,000        
Issuance of common stock resulting from exercise of stock options $ 553       553      
Issuance of common stock resulting from purchase of employee stock purchase plan shares (shares) 113,112     113,000        
Issuance of common stock resulting from purchase of employee stock purchase plan shares $ 369       369      
Issuance of common stock resulting from exercise of warrants (shares)       176,000        
Issuance of common stock resulting from exercise of warrants 246       246      
Issuance of common stock (shares)     4,000 5,493,000        
Issuance of common stock 30,998     $ 6 30,992      
Preferred stock conversion (shares)     5,000 (5,000,000)        
Preferred stock conversion (Series B) 0     $ (5) 5      
Balance at end of period (shares) at Dec. 31, 2019     11,000 55,212,000        
Balance at end of period at Dec. 31, 2019 51,352     $ 55 227,468 (1,995) (174,176)  
Increase (Decrease) in Stockholders' Equity                
Net loss (37,230)           (37,230)  
Foreign currency translation adjustment 1,630         1,630    
Unrealized gain (loss) on investments 70         70    
Stock based compensation expense 5,090       5,090      
Issuance of common stock resulting from exercise of stock options (shares)       149,000        
Issuance of common stock resulting from exercise of stock options $ 291       291      
Issuance of common stock resulting from purchase of employee stock purchase plan shares (shares) 69,544     70,000        
Issuance of common stock resulting from purchase of employee stock purchase plan shares $ 200       200      
Issuance of common stock (shares)       3,571,000        
Issuance of common stock 9,624     $ 4 9,620      
Preferred stock conversion (shares)     3,000 (3,000,000)        
Preferred stock conversion (Series B) 0     $ (3) 3      
Balance at end of period (shares) at Dec. 31, 2020     14,000 56,003,000        
Balance at end of period at Dec. 31, 2020 $ 31,027     $ 56 $ 242,672 $ (295) $ (211,406)